Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-dr

Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-dr

Item
http://www.wikidata.org/entity/Q36985497
Mechanisms of action of therapeutic antibodies for cancerThe development of bispecific antibodies and their applications in tumor immune escape.Multi-specific antibodies for cancer immunotherapy.Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.Ceramide participates in lysosome-mediated cell death induced by type II anti-CD20 monoclonal antibodies.Treatment approaches of hard-to-treat non-Hodgkin lymphomas.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cellsRedirecting T cells to hematological malignancies with bispecific antibodies.Bispecific antibodies in cancer immunotherapy.Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies.Emerging classes of armed antibody therapeutics against cancer
P2860

Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-dr

Item
http://www.wikidata.org/entity/Q36985497
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunotherapy with FBTA05 (Bi2 ...... protocol of an investigator-dr
@en
type
label
Immunotherapy with FBTA05 (Bi2 ...... protocol of an investigator-dr
@en
prefLabel
Immunotherapy with FBTA05 (Bi2 ...... protocol of an investigator-dr
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Immunotherapy with FBTA05 (Bi2 ...... protocol of an investigator-dr
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932